Lifecore Biomedical (LFCR) Stock Analysis: AI Score & Alternative Data
Alt-data signals are cooling for Lifecore Biomedical
Is Lifecore Biomedical a buy right now? The alternative data says hold. This LFCR stock analysis is built on the 25+ alternative data signals AltIndex tracks on Lifecore Biomedical every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 41/100: a Hold. The stock trades at $6.43 with a $244M market cap.
The soft spots over the past 90 days: web traffic down 49.9% to 6K monthly visits, and just 36% of employees report a positive business outlook. The rest of the signal set is holding steady, which keeps LFCR at a hold rather than a sell.
LFCR’s broader alt-data profile also covers job postings (1 open roles), and headcount (281 employees, according to LinkedIn). Every signal links to its own page with full history, the LFCR technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on LFCR is just below.
Lifecore Biomedical AI Stock Analysis
Lifecore Biomedical is a company specializing in the development and manufacturing of biomaterials and medical device components. Primarily, the firm focuses on advanced biomaterial solutions such as hyaluronic acid for various medical applications, including ophthalmology, orthopedics, and drug delivery systems.
Analysis generated October 2, 2026.
Recent Lifecore Biomedical Stock Alerts
|
Lifecore Biomedical | September 28 Price is up by 55.5% in the last 24h. |
|
Lifecore Biomedical | September 9 Price is down by -6.3% in the last 24h. |
|
Lifecore Biomedical | September 3 Price is down by -6% in the last 24h. |
|
Lifecore Biomedical | September 2 Price is up by 7.1% in the last 24h. |
Lifecore Biomedical Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 6K | 49.9% | |
| Job Posts | 1 | 0% | |
| LinkedIn Employees | 281 | 1.4% | |
| Employee Recommend | 41 | 0% | |
| Business Outlook | 36 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 1 | 0% | |
| Stocktwits Mentions | 1 | N/A | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 657 | 0.9% |
About Lifecore Biomedical (LFCR)
Lifecore Biomedical, Inc., is an integrated contract development and manufacturing organization in the United States and internationally. The company is headquartered in Santa Maria, California.
| Price | $6.43 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $244M |
| Year Range | $4 – $9 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Drug Manufacturers |
Latest Lifecore Biomedical News
View more → |
Are RXO, PTC, LFCR, WAFD Obtaining Fair Deals for their Shareholders?October 5 - PRNewswire |
 |
EQUITY ALERT - The M&A Class Action Firm Launches Inquiry -- FWAC, MGLD, LFCR, and MGOctober 3 - PRNewswire |
 |
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Lifecore Biomedical, Inc. (NASDAQ: LFCR)September 29 - PRNewswire |
 |
Are LFCR, ITGR, FHB, INDV Obtaining Fair Deals for their Shareholders?September 29 - PRNewswire |
 |
Webster Equity Partners inks $664m take-private of Lifecore BiomedicalSeptember 29 - Pehub.com |
See Lifecore Biomedical’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for LFCR, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREELifecore Biomedical Earnings & Financial Performance
View all earnings →Lifecore Biomedical Insider Trading Activity
View all →| 22NW, LP filed to sell 264,180 shares at $0.0. May 28 '25 |
| 22NW, LP filed to sell 414,599 shares at $0.0. May 27 '25 |
| 22NW, LP filed to sell 1,554,103 shares at $0.0. May 23 '25 |
| 22NW, LP filed to sell 1,650,240 shares at $0.0. May 13 '25 |
| 22NW, LP filed to sell 1,662,574 shares at $0.0. May 12 '25 |
Lifecore Biomedical Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Lifecore Biomedical
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
SIGA TechnologiesSIGA |
$3.28 0.6% | $236M | 60 |
 |
OrganogenesisORGO |
$1.28 3.0% | $170M | 47 |
 |
Journey MedicalDERM |
$5.95 0.0% | $168M | 49 |
 |
Cardiol TherapeuticsCRDL |
$1.30 1.5% | $160M | 53 |
 |
vTv TherapeuticsVTVT |
$30.08 3.0% | $119M | 56 |
Explore Lifecore Biomedical Data
Frequently Asked Questions: Lifecore Biomedical (LFCR)
Lifecore Biomedical has an AltIndex AI Score of 41/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
41/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Lifecore Biomedical (LFCR) stock is $6.43 with a market cap of $244M.
As of today, Lifecore Biomedical’s PE (Price to Earnings) ratio is —.
View the latest Lifecore Biomedical insider transactions to see recent buying and selling activity by company executives and directors.
Check the Lifecore Biomedical congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The LFCR stock price chart above shows Lifecore Biomedical’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Lifecore Biomedical technical analysis for RSI, moving averages, and more.
See the stocks similar to Lifecore Biomedical section on this page for companies in the same industry ranked by market cap and AI Score.
